Nitib Ibrutinib 140 Mg Capsules

140 Mg Capsules , Bottle

4.5 (154)

8,000

Nitib Ibrutinib 140mg Capsule is an anticancer medicine used to treat mantle cell lymphoma and chronic lymphocytic leukemia (CLL). It works by blocking Bruton’s tyrosine kinase (BTK), a protein that helps cancer cells grow and multiply, thereby slowing or stopping their spread. Take this medicine exactly as prescribed by your doctor. Regular blood tests may be required to monitor blood cell counts during treatment. Common side effects include headache, nausea, diarrhea, and an increased risk of infections due to reduced blood cells.

Description

Introduction Of Nitib Ibrutinib 140mg Capsule:

Nitib Ibrutinib 140mg Capsule is used in the treatment of mantle-cell lymphoma and blood cancer (chronic lymphocytic leukemia). It is also used in chronic lymphocytic leukaemia who have received at least one prior therapy.

Nitib Ibrutinib 140mg Capsule is taken in a dose as advised by the doctor. The duration of treatment varies on the basis of your response to treatment. Your doctor may get regular blood tests to check number of blood cells during treatment with this medicine. It is known to reduce the number of blood cells in your blood thereby, increasing the susceptibility to infections. It may cause headache, diarrhea, and nausea as its side effects.

Uses Of Nitib Ibrutinib 140mg Capsule:

  • Mantle-cell lymphoma
  • Blood cancer (Chronic lymphocytic leukemia)

Side Effects Of Nitib Ibrutinib 140mg Capsule:

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Machanism Of Action Of Nitib Ibrutinib 140mg Capsule:

Nitib Ibrutinib 140mg Capsule is a Bruton’s tyrosine kinase inhibitor. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.

Contact Us

Info Table
Brand Nitib 140mg
Form Capsule
Pack Size 30 capsules in 1 bottle
Packaging Type Bottle
Composition Ibrutinib 140mg
Usage/Application Mantle-cell lymphoma, Blood cancer
Country of Origin Made in India
Vendor Info
Benefits
Reviews

Description

Introduction Of Nitib Ibrutinib 140mg Capsule:

Nitib Ibrutinib 140mg Capsule is used in the treatment of mantle-cell lymphoma and blood cancer (chronic lymphocytic leukemia). It is also used in chronic lymphocytic leukaemia who have received at least one prior therapy.

Nitib Ibrutinib 140mg Capsule is taken in a dose as advised by the doctor. The duration of treatment varies on the basis of your response to treatment. Your doctor may get regular blood tests to check number of blood cells during treatment with this medicine. It is known to reduce the number of blood cells in your blood thereby, increasing the susceptibility to infections. It may cause headache, diarrhea, and nausea as its side effects.

Uses Of Nitib Ibrutinib 140mg Capsule:

  • Mantle-cell lymphoma
  • Blood cancer (Chronic lymphocytic leukemia)

Side Effects Of Nitib Ibrutinib 140mg Capsule:

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Machanism Of Action Of Nitib Ibrutinib 140mg Capsule:

Nitib Ibrutinib 140mg Capsule is a Bruton’s tyrosine kinase inhibitor. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.

Contact Us

Reviews

There are no reviews yet.

Be the first to review “Nitib Ibrutinib 140 Mg Capsules”

Your email address will not be published. Required fields are marked *

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Nitib Ibrutinib 140mg Capsule used for?
Nitib Ibrutinib 140 mg Capsule is used to treat mantle cell lymphoma and chronic lymphocytic leukemia (CLL), including patients who’ve already received at least one prior therapy.
It’s a Bruton’s tyrosine kinase (BTK) inhibitor that blocks the abnormal protein signaling cancer cells to multiply, helping stop or slow the spread of cancer.
It should be taken in the dose advised by your doctor, with treatment duration depending on how well you respond.
Common side effects include headache, nausea, diarrhea, and an increased risk of infections due to reduced blood cell counts.
Regular blood tests may be required to monitor blood cell counts throughout treatment.
For detailed clinical and safety information, refer to MedlinePlus Drug Information, a trusted external medical resource.

Related products